Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RVTY · against 116 other Healthcare companies of similar size
Ranked #80 of 117 · scores higher than 30% of peers
Bars: peers in each 10-point band of the valuation score20 peers with a valuation score of 40–49, including RVTY · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | RVTY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 115 reported | 1.3% | 3.2% | 25% | 30% | |
| EBITDA yieldHigher is better · 117 reported | 4.3% | 5.4% | 35% | 50% | |
| Free cash flow yieldHigher is better · 76 reported | 3.1% | 3.7% | 43% | 20% | |
| Book yieldHigher is better · 111 reported | 39.6% | 21.4% | 75% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 10.4B USD | 96 | 64 | |
| 3 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 3 | 21.5B USD | 95 | 60 | |
| 5 | 11.6B USD | 94 | 58 | |
| 77 | 10.8B USD | 49 | 35 | |
| 77 | 32.3B AUD (≈$21.3B) | 49 | 55 | |
| 77 | 15.8B EUR (≈$17.4B) | 49 | 47 | |
| 80 | 12.3B USD | 48 | 35 | |
| 80 | 18.2B USD | 48 | 40 | |
| 80 | 28.6B USD | 48 | 60 | |
| 83 | 43.30T KRW (≈$31.2B) | 47 | 68 | |
| 84 | 81.4B CNY (≈$11.4B) | 46 | 55 | |
| 84 | 21.7B EUR (≈$23.9B) | 46 | 47 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score